Healthcare Executive · Entrepreneur · Marine Veteran
John T. Garcia
Transformative leader with 15+ years building commercial organizations and launching breakthrough therapies across biopharma and medical devices. From the Marine Corps to the C-suite, driven by a mission to deliver meaningful healthcare solutions.
USMC Major
Combat Veteran
12+ Launches
Biopharma & Device
UC Berkeley
MBA, Haas
Naval Academy
BS Graduate
Career Journey
From the battlefield to the boardroom — building organizations that transform patients' lives.
AlphaRose Therapeutics
Chief Commercial Officer
Leading commercialization strategy for therapies targeting ultra-rare genetic diseases. Driving Series A fundraising and licensing activities with four near-term in-licensing opportunities.
Hekla Ventures
CEO & Founder
Private holding company with portfolio spanning energy technology, real estate, and climate solutions across New England.
Krystal Biotech
SVP, US Commercial
Built the US commercial organization from scratch to 50+ employees. Led the successful launch of VYJUVEK™—the first gene therapy for dystrophic epidermolysis bullosa.
Alnylam Pharmaceuticals
VP, Global & US Business Operations
Delivered 12 consecutive quarters of earnings beats. Launched the first three RNAi therapeutics ever across 40+ countries, scaling the organization to hundreds of employees.
Alexion Pharmaceuticals
Sr. Director, Global Commercial Ops
Led global commercial operations across 60+ countries. Core to the launch of Strensiq and Kanuma—both ultra-orphan therapeutics.
Biogen
Director of Operations
Managed regional operations and large sales teams, driving commercial excellence across the organization.
Hologic / Cytyc
Regional Manager
Led territory and regional sales operations in the medical device space.
United States Marine Corps
Major, Infantry Unit Commander
Commanded units of 200+ personnel during Operation Enduring Freedom. Combat leadership forging the foundation of an “own-it” leadership philosophy. Retired Major.
A proven team builder and operational strategist who excels in developing early-stage ventures, driving high revenue growth, and creating sustainable businesses with a patient-centric approach.
Leadership Philosophy
Hekla Ventures
A private holding company building at the intersection of energy, technology, real estate, and climate solutions.
Maine Energy
Redefining Home Heating
Co-founded residential heat pump company redefining home heating efficiency across New England. Making sustainable energy accessible to every household.
HITA Energy
AI Infrastructure Innovation
Co-founded AI infrastructure company deploying on-premises LLMs with pioneering waste heat recycling technology. Where computing meets climate solutions.
Real Estate Portfolio
Community-Centered Living
Managing mobile home park portfolio across central and northern Maine, providing affordable housing solutions and community-centered living.
About John
John Garcia is a transformative healthcare executive with a distinguished career spanning military service, biopharma, and entrepreneurship. As CEO of Hekla Ventures, he leads multiple innovative startups including Maine Energy, HITA Energy, and a real estate portfolio — ventures revolutionizing home heating, AI computing, and community living respectively.
Previously, as SVP US Business at Krystal Biotech, John spearheaded the successful launch of VYJUVEK™, securing FDA approval in May 2023 and establishing value-based agreements with major US payers. At Alnylam, he made history by launching the first three RNAi therapies across 40 countries, achieving twelve consecutive quarters of earnings beats. He pioneered breakthrough patient discovery approaches using machine learning and forged innovative partnerships with 23andMe and other organizations to accelerate diagnosis.
John's leadership philosophy was forged during his service as a Marine Corps Major, where he commanded units of 200+ personnel during Operation Enduring Freedom. The foundation of his approach combines strategic vision with authentic leadership and an "own-it" mentality — building diverse teams focused on transforming patients' lives through meaningful service and product delivery.
By the Numbers
15+
Years in Biopharma
12+
Product Launches
$600M+
Revenue Generated
40+
Countries Reached
600+
Team Members Built
10
Rare Disease Treatments
Education
MBA
Haas School of Business, UC Berkeley
BS
United States Naval Academy
Board & Advisory
Board of Directors
Avvio Medical
Advisory Roles
PuraCath Medical, Thimble Bioelectronics, Fun2Rent
Get in Touch
Interested in connecting about biopharma commercialization, entrepreneurship, or potential collaborations? I'd love to hear from you.